Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Talzenna (talazoparib) for the Treatment of Advanced Breast Cancer

The FDA approval of Talzenna was based on data from the Phase III clinical study known as Embraca. Image courtesy of Pfizer.



  • Talzenna (talazoparib)
  • Talzenna (talazoparib)
  • Talzenna (talazoparib)

Go Top